lactic acid has been researched along with Hepatitis B in 13 studies
Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.
Hepatitis B: INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In contrast, in Himalayan marmots treated with AZT we observed delayed toxicity, including lactic acidosis, severe hepatic steatosis, obvious mitochondrial damage, and significant decreases in respiratory chain complex enzyme activity and mtDNA content." | 7.77 | Evaluation of mitochondrial toxicity in Marmota himalayana treated with metacavir, a novel 2',3'-dideoxyguanosine prodrug for treatment of hepatitis B Virus. ( Chen, H; Hu, M; Jiang, Z; Li, Z; Tao, Y; Xiong, Y; Zhang, L; Zhang, P, 2011) |
| "Poly (L-lactic acid) (PLA) microparticles encapsulating Hepatitis B surface antigen (HBsAg) with alum and chitosan were investigated for their potential as a vaccine delivery system." | 7.74 | Enhancement of immune response of HBsAg loaded poly (L-lactic acid) microspheres against hepatitis B through incorporation of alum and chitosan. ( Alpar, HO; Cevher, E; Pandit, S; Somavarapu, S; Zariwala, MG, 2007) |
| " In contrast, in Himalayan marmots treated with AZT we observed delayed toxicity, including lactic acidosis, severe hepatic steatosis, obvious mitochondrial damage, and significant decreases in respiratory chain complex enzyme activity and mtDNA content." | 3.77 | Evaluation of mitochondrial toxicity in Marmota himalayana treated with metacavir, a novel 2',3'-dideoxyguanosine prodrug for treatment of hepatitis B Virus. ( Chen, H; Hu, M; Jiang, Z; Li, Z; Tao, Y; Xiong, Y; Zhang, L; Zhang, P, 2011) |
| "Poly (L-lactic acid) (PLA) microparticles encapsulating Hepatitis B surface antigen (HBsAg) with alum and chitosan were investigated for their potential as a vaccine delivery system." | 3.74 | Enhancement of immune response of HBsAg loaded poly (L-lactic acid) microspheres against hepatitis B through incorporation of alum and chitosan. ( Alpar, HO; Cevher, E; Pandit, S; Somavarapu, S; Zariwala, MG, 2007) |
| "The most common causes of ALF were indeterminate liver failure (21%), acute hepatitis B (18%), acetaminophen ingestion (16%), and Budd-Chiari syndrome (9%)." | 3.74 | Prognostic implications of lactate, bilirubin, and etiology in German patients with acute liver failure. ( Bahr, MJ; Hadem, J; Klempnauer, J; Manns, MP; Rifai, K; Schneider, AS; Stiefel, P; Tillmann, HL; Wedemeyer, H, 2008) |
| "Acute liver failure is often accompanied by hyperdynamic circulation, which is also a characteristic of septic shock." | 1.35 | Hemodynamics and metabolic studies on septic shock in patients with acute liver failure. ( Chen, PC; Chen, YC; Chu, YY; Fang, JT; Lien, JM; Peng, YS; Tang, JH; Tian, YC; Tsai, MH; Wu, CS; Yang, C, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (15.38) | 18.2507 |
| 2000's | 7 (53.85) | 29.6817 |
| 2010's | 2 (15.38) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Mohammed, MM | 1 |
| Naif, HM | 1 |
| Nie, Y | 1 |
| Liu, LX | 1 |
| Chen, T | 1 |
| Zhang, Y | 2 |
| Zhu, X | 1 |
| Tsai, MH | 1 |
| Chen, YC | 1 |
| Lien, JM | 1 |
| Tian, YC | 1 |
| Peng, YS | 1 |
| Fang, JT | 1 |
| Yang, C | 1 |
| Tang, JH | 1 |
| Chu, YY | 1 |
| Chen, PC | 1 |
| Wu, CS | 1 |
| Jain, AK | 1 |
| Goyal, AK | 1 |
| Gupta, PN | 1 |
| Khatri, K | 1 |
| Mishra, N | 1 |
| Mehta, A | 1 |
| Mangal, S | 1 |
| Vyas, SP | 1 |
| Zhang, P | 1 |
| Zhang, L | 1 |
| Jiang, Z | 1 |
| Xiong, Y | 1 |
| Chen, H | 1 |
| Tao, Y | 1 |
| Hu, M | 1 |
| Li, Z | 1 |
| Giri, N | 1 |
| Tomar, P | 1 |
| Karwasara, VS | 1 |
| Pandey, RS | 1 |
| Dixit, VK | 1 |
| van de Kerkhove, MP | 1 |
| Di Florio, E | 1 |
| Scuderi, V | 1 |
| Mancini, A | 1 |
| Belli, A | 1 |
| Bracco, A | 1 |
| Scala, D | 1 |
| Scala, S | 1 |
| Zeuli, L | 1 |
| Di Nicuolo, G | 1 |
| Amoroso, P | 1 |
| Calise, F | 1 |
| Chamuleau, RA | 1 |
| He, X | 1 |
| Jiang, L | 1 |
| Wang, F | 1 |
| Xiao, Z | 1 |
| Li, J | 1 |
| Liu, LS | 1 |
| Li, D | 1 |
| Ren, D | 1 |
| Jin, X | 1 |
| Li, K | 1 |
| He, Y | 1 |
| Shi, K | 1 |
| Guo, Y | 1 |
| Sun, S | 1 |
| Pandit, S | 1 |
| Cevher, E | 1 |
| Zariwala, MG | 1 |
| Somavarapu, S | 1 |
| Alpar, HO | 1 |
| Hadem, J | 1 |
| Stiefel, P | 1 |
| Bahr, MJ | 1 |
| Tillmann, HL | 1 |
| Rifai, K | 1 |
| Klempnauer, J | 1 |
| Wedemeyer, H | 1 |
| Manns, MP | 1 |
| Schneider, AS | 1 |
| Lee, MY | 1 |
| Wang, SS | 1 |
| Lu, CW | 1 |
| Chao, Y | 1 |
| Lee, FY | 1 |
| Wu, SL | 1 |
| Lee, SD | 1 |
| Tsai, YT | 1 |
| Lo, KJ | 1 |
| Cui, L | 1 |
| Schinazi, RF | 1 |
| Gosselin, G | 1 |
| Imbach, JL | 1 |
| Chu, CK | 1 |
| Rando, RF | 1 |
| Revankar, GR | 1 |
| Sommadossi, JP | 1 |
| Moynihan, JS | 1 |
| Jones, DH | 1 |
| Farrar, GH | 1 |
| Howard, CR | 1 |
1 trial available for lactic acid and Hepatitis B
| Article | Year |
|---|---|
Bridging a patient with acute liver failure to liver transplantation by the AMC-bioartificial liver.
Topics: Adult; Ammonia; Animals; Bilirubin; Female; Hepatitis B; Hepatocytes; Humans; Lactic Acid; Liver Fai | 2003 |
12 other studies available for lactic acid and Hepatitis B
| Article | Year |
|---|---|
Poly(Lactide-
Topics: Adjuvants, Immunologic; Antigens, Surface; Hepatitis B; Hepatitis B Vaccines; Hepatitis B virus; Hum | 2022 |
Serum lactate level predicts 6-months mortality in patients with hepatitis B virus-related decompensated cirrhosis: a retrospective study.
Topics: Aged; Ascites; Carcinoma, Hepatocellular; Female; gamma-Glutamyltransferase; Hepatitis B; Hepatitis | 2021 |
Hemodynamics and metabolic studies on septic shock in patients with acute liver failure.
Topics: Aldosterone; APACHE; Blood Gas Analysis; Female; Hemodynamics; Hepatitis B; Hospital Mortality; Huma | 2008 |
Synthesis, characterization and evaluation of novel triblock copolymer based nanoparticles for vaccine delivery against hepatitis B.
Topics: Animals; Drug Delivery Systems; Female; Hepatitis B; Hepatitis B Vaccines; Lactic Acid; Mice; Mice, | 2009 |
Evaluation of mitochondrial toxicity in Marmota himalayana treated with metacavir, a novel 2',3'-dideoxyguanosine prodrug for treatment of hepatitis B Virus.
Topics: Acidosis, Lactic; Animals; Antiviral Agents; Dideoxynucleosides; DNA, Mitochondrial; Fatty Liver; He | 2011 |
Targeted novel surface-modified nanoparticles for interferon delivery for the treatment of hepatitis B.
Topics: Animals; Drug Delivery Systems; Female; Hepatitis B; Hepatitis B Surface Antigens; Humans; Interfero | 2011 |
Augmented humoral and cellular immune responses to hepatitis B DNA vaccine adsorbed onto cationic microparticles.
Topics: Adsorption; Animals; Antibody Formation; Blotting, Western; Cations; CD4-Positive T-Lymphocytes; CD8 | 2005 |
Enhancement of immune response of HBsAg loaded poly (L-lactic acid) microspheres against hepatitis B through incorporation of alum and chitosan.
Topics: Aluminum Hydroxide; Animals; Capsules; Cells, Cultured; Chitosan; Cytokines; Drug Carriers; Hepatiti | 2007 |
Prognostic implications of lactate, bilirubin, and etiology in German patients with acute liver failure.
Topics: Acetaminophen; Adolescent; Adult; Aged; Analgesics, Non-Narcotic; Bilirubin; Biomarkers; Budd-Chiari | 2008 |
Diagnostic parameters for spontaneous bacterial peritonitis in hepatitis B-related cirrhosis: comparison of ascitic fluid polymorphonuclear cell count, lactate and pH values.
Topics: Adult; Aged; Aged, 80 and over; Ascitic Fluid; Bacterial Infections; Female; Hepatitis B; Humans; Hy | 1994 |
Effect of beta-enantiomeric and racemic nucleoside analogues on mitochondrial functions in HepG2 cells. Implications for predicting drug hepatotoxicity.
Topics: Antiviral Agents; Cell Division; Cell Line; DNA, Mitochondrial; Drug Evaluation, Preclinical; Hepati | 1996 |
A novel microencapsulated peptide vaccine against hepatitis B.
Topics: Amino Acid Sequence; Animals; Capsules; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Sur | 2001 |